Ian E. Smith
Breast Unit
Royal Marsden Hospital
London
and the Institute of Cancer Research
UK
Name/email consistency: high
- First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients. Smith, I.E., Pierga, J.Y., Biganzoli, L., Cortés-Funes, H., Thomssen, C., Pivot, X., Fabi, A., Xu, B., Stroyakovskiy, D., Franke, F.A., Kaufman, B., Mainwaring, P., Pienkowski, T., De Valk, B., Kwong, A., González-Trujillo, J.L., Koza, I., Petrakova, K., Pereira, D., Pritchard, K.I. Ann. Oncol. (2011)
- Targeting HER2 in the adjuvant setting: dealing with new standards and with open questions. Smith, I.E. Breast (2009)
- The follow-up of women at high risk for breast cancer relapse. Smith, I.E., Banerjee, S. Breast (2009)
- Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy?. Smith, I.E. Breast Cancer Res. (2009)
- Debate: tailored targeted therapy for all--a realistic and worthwhile objective? Introduction to Session 2. Smith, I.E. Breast Cancer Res. (2009)
- Neoadjuvant/presurgical treatments. Smith, I.E. Breast Cancer Res. (2008)
- The evolution of adjuvant endocrine therapy: developments since St Gallen 2005. Smith, I.E., Arnedos, M. Breast (2007)
- A phase II placebo-controlled trial of neoadjuvant anastrozole alone or with gefitinib in early breast cancer. Smith, I.E., Walsh, G., Skene, A., Llombart, A., Mayordomo, J.I., Detre, S., Salter, J., Clark, E., Magill, P., Dowsett, M. J. Clin. Oncol. (2007)
- 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Smith, I., Procter, M., Gelber, R.D., Guillaume, S., Feyereislova, A., Dowsett, M., Goldhirsch, A., Untch, M., Mariani, G., Baselga, J., Kaufmann, M., Cameron, D., Bell, R., Bergh, J., Coleman, R., Wardley, A., Harbeck, N., Lopez, R.I., Mallmann, P., Gelmon, K., Wilcken, N., Wist, E., Sánchez Rovira, P., Piccart-Gebhart, M.J. Lancet (2007)
- Goals of treatment for patients with metastatic breast cancer. Smith, I. Semin. Oncol. (2006)
- Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelines. Smith, I.E., Dowsett, M., Yap, Y.S., Walsh, G., Lønning, P.E., Santen, R.J., Hayes, D. J. Clin. Oncol. (2006)
- Overview of gemcitabine activity in advanced breast cancer. Smith, I.E. Semin. Oncol. (2006)
- Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial. Smith, I.E., Dowsett, M., Ebbs, S.R., Dixon, J.M., Skene, A., Blohmer, J.U., Ashley, S.E., Francis, S., Boeddinghaus, I., Walsh, G. J. Clin. Oncol. (2005)
